New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

China's pharma influence is growing, FDA says

As China’s role expands, FDA has significantly increased drug and medical device inspections there.

Face-to-face conversation about FDASIA, and other regulations, were invaluable to FDA officials during a recent trip to China.

In a post written for FDA's The Voice blog, Howard Sklamberg, Richard Moscicki, M.D., and Alonza Cruse talked about their trip which included a meeting with Chinese Food and Drug Administration, a tour of a Chinese pharmaceutical manufacturing plant and an event hosted by China’s Pharmaceutical University in Nanjing

"We had productive discussions with the Chinese about how seriously we are committed to making sure that everyone in the drug supply chain – from the companies that make the active ingredients to those that provide the packaging –shares in this collective commitment to quality," the blog post read.

They also wrote, "China is a major provider of many of the active ingredients in finished drug products Americans rely on every day."

For this reason, in part, FDA continues to increase their drug and medical device inspections in China, according to the post.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader